Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Automobiles × CNS × Clear all

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 CNS 1

Conditions

Gliosarcoma 1 Glioblastoma 1

Interventions

Temozolomide 76 Radiotherapy 37 Bevacizumab 32 Radiosurgery 19 Magnetic Resonance Spectroscopy 16 Cyclophosphamide 16 Irinotecan 13 Radiation 12 Carboplatin 12 Topotecan 11 Filgrastim 10 Radiotherapy, Intensity-Modulated 9 Nivolumab 9 Etoposide 9 Erlotinib Hydrochloride 9 pembrolizumab 8 Lomustine 8 Granulocyte Colony-Stimulating Factor 8 Granulocyte-Macrophage Colony-Stimulating Factor 7 Everolimus 7 Carmustine 7 sargramostim 6 TPI-287 6 Mental Status and Dementia Tests 6 Melphalan 6 Isotretinoin 6 Ipilimumab 6 Imatinib Mesylate 6 Capecitabine 6 poly ICLC 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02664363 2023-02-17

ExCeL

Duke University

Phase 1 Terminated

3 enrolled 8 charts

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡